I don't have any doubt that anti-PD1 will work well with bavi. I think better than anti-CTLA4, with fewer side effects. I hope that data turns up soon. I like the slides. Slide 17 is very interesting. I would like more info about it. If you look at the poster from the annual SITC meeting in October there is some info about the numbers of mice etc. The immunohistochemistry (IHC) stuff is new. http://www.peregrineinc.com/images/stories/pdfs/sitc_172_gong.pdf